ID25698A - Proses pembuatan granul semprot yang mengandung riboflavin - Google Patents

Proses pembuatan granul semprot yang mengandung riboflavin

Info

Publication number
ID25698A
ID25698A IDP20000337A ID20000337A ID25698A ID 25698 A ID25698 A ID 25698A ID P20000337 A IDP20000337 A ID P20000337A ID 20000337 A ID20000337 A ID 20000337A ID 25698 A ID25698 A ID 25698A
Authority
ID
Indonesia
Prior art keywords
granul
making
spray drying
drying process
spray containing
Prior art date
Application number
IDP20000337A
Other languages
English (en)
Indonesian (id)
Inventor
Markus Nowotny
Jean-Claude Tritsch
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8238078&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID25698(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ID25698A publication Critical patent/ID25698A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/12—Heterocyclic compounds containing pteridine ring systems containing pteridine ring systems condensed with carbocyclic rings or ring systems
    • C07D475/14—Benz [g] pteridines, e.g. riboflavin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDP20000337A 1999-04-30 2000-04-26 Proses pembuatan granul semprot yang mengandung riboflavin ID25698A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99108476 1999-04-30

Publications (1)

Publication Number Publication Date
ID25698A true ID25698A (id) 2000-11-02

Family

ID=8238078

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP20000337A ID25698A (id) 1999-04-30 2000-04-26 Proses pembuatan granul semprot yang mengandung riboflavin

Country Status (16)

Country Link
US (1) US6723346B1 (fr)
EP (1) EP1048668B2 (fr)
JP (1) JP4965013B2 (fr)
KR (1) KR100720202B1 (fr)
CN (1) CN1198595C (fr)
AT (1) ATE231864T1 (fr)
AU (1) AU770320B2 (fr)
BR (1) BR0002390A (fr)
CA (1) CA2306502A1 (fr)
DE (1) DE60001286T3 (fr)
DK (1) DK1048668T3 (fr)
ES (1) ES2189711T5 (fr)
ID (1) ID25698A (fr)
MX (1) MXPA00004185A (fr)
NO (1) NO318219B1 (fr)
TW (1) TWI253347B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0219815D0 (en) * 2002-08-24 2002-10-02 Accentus Plc Preparation of small crystals
DE10317051A1 (de) * 2003-04-11 2004-10-21 Basf Ag Verfahren zur Herstellung von Riboflavin der Modifikation B/C in Granulatform
ES2332787T3 (es) * 2003-07-22 2010-02-12 Dsm Ip Assets B.V. Procedimiento para la purificacion de rivoflavina.
EP2107934B1 (fr) * 2006-12-07 2019-11-20 FrieslandCampina Nederland B.V. Procédé et appareil de séchage par pulvérisation
CN104961740B (zh) * 2015-06-02 2016-04-27 湖北广济药业股份有限公司 一种含核黄素的固体制剂及其制备方法
BR112021008614A2 (pt) 2018-11-07 2021-11-03 Dsm Ip Assets Bv Medicamentos que contêm riboflavina que exibem fluidez aprimorada

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE91686T1 (de) * 1987-09-18 1993-08-15 Hoffmann La Roche Neue form des riboflavins.
DE3819745A1 (de) * 1988-06-10 1989-12-14 Basf Ag Verfahren zur herstellung von auf mikrobiellem wege hergestelltem riboflavin in form von sprueh- oder mikrogranulaten
JP2634285B2 (ja) * 1989-03-28 1997-07-23 積水化学工業株式会社 放射性物質取扱所の被覆材用非灰分性樹脂組成物
DE3927810A1 (de) 1989-08-23 1991-02-28 Basf Ag Riboflavingranulate
US5236920A (en) * 1990-04-30 1993-08-17 Basf Corporation Granulated riboflavin product having high flowability, high riboflavin content
US4994458A (en) * 1990-04-30 1991-02-19 Basf Corporation Process for rotary fluid bed granulation of riboflavin
DE4014262A1 (de) 1990-05-04 1991-11-07 Basf Ag Gut rieselfaehige, nichtstaubende bindemittelfreie riboflavinspruehgranulate oder -mikrogranulate aus reinem riboflavin und ein verfahren zu deren herstellung
US5000888A (en) * 1990-05-23 1991-03-19 Basf Corporation Process for spray drying riboflavin to produce a granulate product having low binder content
JP2000112883A (ja) * 1998-09-24 2000-04-21 Internatl Business Mach Corp <Ibm> 情報処理方法、情報処理装置、情報処理プログラムを格納する記憶媒体
CA2282908A1 (fr) 1998-10-19 2000-04-19 F. Hoffmann-La Roche Ag Procede de purification et de cristallisation de la riboflavine
US6093715A (en) * 1999-03-24 2000-07-25 Basf Aktiengesellschaft Process for producing riboflavin-containing granules

Also Published As

Publication number Publication date
DE60001286T3 (de) 2010-10-28
NO318219B1 (no) 2005-02-21
JP2000327562A (ja) 2000-11-28
MXPA00004185A (es) 2002-03-08
CN1198595C (zh) 2005-04-27
KR20010029668A (ko) 2001-04-06
JP4965013B2 (ja) 2012-07-04
ATE231864T1 (de) 2003-02-15
NO20002283L (no) 2000-10-31
CA2306502A1 (fr) 2000-10-30
NO20002283D0 (no) 2000-04-28
EP1048668B2 (fr) 2010-06-09
EP1048668A3 (fr) 2001-03-28
DE60001286T2 (de) 2003-11-06
AU3018900A (en) 2000-11-02
DE60001286D1 (de) 2003-03-06
EP1048668A2 (fr) 2000-11-02
DK1048668T3 (da) 2003-05-26
BR0002390A (pt) 2000-10-31
ES2189711T3 (es) 2003-07-16
AU770320B2 (en) 2004-02-19
EP1048668B1 (fr) 2003-01-29
KR100720202B1 (ko) 2007-05-21
CN1275375A (zh) 2000-12-06
US6723346B1 (en) 2004-04-20
ES2189711T5 (es) 2010-07-28
TWI253347B (en) 2006-04-21

Similar Documents

Publication Publication Date Title
YU70901A (sh) Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
CA2334775A1 (fr) Derives de benzo(b)thiepine-1,1-dioxyde, leur procede de preparation, medicaments contenant ces composes, et leur utilisation
SI1155015T1 (sl) Postopek za proizvodnjo terc.-butil (E)-(6-(2-(4-(4-fluorofenil)-6- izopropil-2-(metil(metilsulfonil)amino)pirimidin-5-il)vinil)(4R,6S)-2, 2-dimetil-(1,3)dioksan-4-il)acetata
IL94887A0 (en) Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives
FI113651B (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsoliyhdisteiden valmistamiseksi
MX9200817A (es) Derivados de piranil cianoguanidina y proceso para su preparacion.
FI102069B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi
BRPI0116967B8 (pt) derivado de pirazina ou um sal deste, composição farmacêutica, e, derivado de fluoropirazina ou um sal deste
WO2001014379A3 (fr) Nouvelle forme cristalline de disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l- sel d&#39;acide glutamique et procedes de preparation
WO2002102787A3 (fr) Nouveaux derives d&#39;acide sulfonique
ID25698A (id) Proses pembuatan granul semprot yang mengandung riboflavin
NZ514037A (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders
NO20016389L (no) Fremgangsmåte for fremstilling av substituerte cyklopentanderivater og nye krystallinske strukturer derav
HK1012366A1 (en) Process for the preparation of cyano-methoxyiminomethyl derivatives
ATE272617T1 (de) Sulfonamid-derivate
EP0314098A3 (en) Imide derivatives, their production and use
WO1999062888A8 (fr) Composes aza-heterocycliques pouvant traiter des troubles neurologiques et la chute des cheveux
EP0302967A3 (en) Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient
DK0717042T3 (da) Fremgangsmåde til fremstilling af 1-(4,5-dihydro-2-thiazolyl)-3-azetidin-thiol-derivater
BRPI0013751B8 (pt) processo para produção de derivados de ácido naftiridina-3-carboxílico.
EP0703232A3 (fr) Dérivés de 2,3-dihydro-1H-isoindole, procédé pour leur préparation et leur utilisation comme inhibiteurs de la réassimilation de sérotonine
DK0855398T3 (da) Sesquiterpenderivater med antiviral aktivitet
WO2003004464A8 (fr) Derives d&#39;amide heterocycliques
HUP0300505A2 (en) Process for the preparation of acylated 1,3-dicarbonyl compounds
WO2005065655A3 (fr) Procede de production de granules d&#39;acide ceto-l-gulonique obtenus par pulverisation